Gerresheimer (GXI.DE) stock: key figures, P/E, revenue and dividend
Health Care · Germany · ISIN DE000A0LD6E6
Gerresheimer financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 2.04 bn EUR | 2.32 bn EUR |
| Gross profit | 607.00 m EUR | 425.00 m EUR |
| Operating income | 217.05 m EUR | – |
| EBIT | 197.00 m EUR | -209.00 m EUR |
| Net income | 109.00 m EUR | -320.00 m EUR |
| Diluted EPS – continuing operations | 3.18 EUR | -9.27 EUR |
Full history since 2005, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Gerresheimer
Gerresheimer AG, together with its subsidiaries, provides drug containment solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and containers, bottles, caps, closures, applicators, and accessories; development, industrialization, and contract manufacturing of drug delivery programs; project and quality management; and drug delivery devices, including inhalers, injection/auto injectors, and pen injectors. The company also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, it offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. The company offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.
More stocks
- NEKTAR THERAPEUTICS (NKTR)
- Gansu Jiu Steel Group Hongxing Iron & Steel Co Ltd (600307.SS)
- West China Cement Ltd (2233.HK)
- Taiwan Fertilizer Co Ltd (1722.TW)
- LB PHARMACEUTICALS INC (LBRX)
- Guangdong High Dream Intellectualized Machinery Co Ltd Class A (300720.SZ)
- Rai Way SpA (RWAY.MI)
- Icade SA (ICAD.PA)
- Scottish American Investment Company PLC (SAIN.L)
- Grupo Nacional Provincial S.A.B (GNP.MX)
- Clariane SE (CLARI.PA)
- ZoomInfo Technologies Inc. (GTM)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.